Connect your AI

Innoviva, Inc. INVA Other Working Capital

Other Working Capital at other companies

InsmedINSM

$5.11M+1.8%

Ligand PharmaceuticalsLGND

-$547K-160%

AlkermesALKS

-$717K-135%

OrganonOGN

-$8M+80.0%

United TherapeuticsUTHR

-$27M+79.9%

Option Care Health, Inc.OPCH

$391K+141%

Other financials

Income statement

Revenue$98.0M+10.6%

Gross profit$75.8M+3.4%

Operating income$38.2M-7.9%

Net income$186.6M+501%

EPS (diluted)$2.22+400%

Balance sheet

Cash & equivalents$603.1M+89.0%

Total debt$269.4M-40.3%

Total equity$1.3B—

Total assets$1.8B+46.4%

Cash flow

Operating cash flow$35.3M-27.4%

CapEx$492.0K—

Free cash flow$34.8M-28.4%

Valuation

Market cap$1.74B+51.8%

Enterprise value$1.41B+9.7%

P/E3.5×—

P/S4.2×+1.0×

Profitability

Gross margin73.7%-9.9pp

Operating margin38.1%-11.2pp

Net margin119.9%+107pp

FCF margin54.1%+5.3pp

Returns & leverage

Return on equity29.1%—

Debt / equity0.2×—

Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Innoviva, Inc.'s other working capital?: Innoviva, Inc. (INVA) reported other working capital of -$1.03M in Q1 2026.
How has Innoviva, Inc.'s other working capital changed year-over-year?: Innoviva, Inc.'s other working capital decreased by 28.4% year-over-year, from -$799K to -$1.03M.
What does other working capital mean?: Net change in working capital items not separately classified — a residual balancing item.